M. Mullarkey

401 total citations
15 papers, 298 citations indexed

About

M. Mullarkey is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, M. Mullarkey has authored 15 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Neurology. Recurrent topics in M. Mullarkey's work include Genomic variations and chromosomal abnormalities (6 papers), Neuroblastoma Research and Treatments (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). M. Mullarkey is often cited by papers focused on Genomic variations and chromosomal abnormalities (6 papers), Neuroblastoma Research and Treatments (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). M. Mullarkey collaborates with scholars based in Ireland, United Kingdom and United States. M. Mullarkey's co-authors include Michael McDermott, Anne O’Meara, R.L. Stallings, M Fitchett, Piers E.F. Daubeney, Andrew O.M. Wilkie, David Grant, R.J. Daniels, Nabeel A. Affara and Susan Huson and has published in prestigious journals such as The Lancet, Proceedings of the Royal Society B Biological Sciences and Biochemical Society Transactions.

In The Last Decade

M. Mullarkey

15 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Mullarkey Ireland	9	197	170	94	32	30	15	298
Sandrine Aegerter France	6	116 0.6×	146 0.9×	28 0.3×	8 0.3×	34 1.1×	6	502
Eugene J. Gardner United Kingdom	13	566 2.9×	267 1.6×	9 0.1×	27 0.8×	20 0.7×	24	769
Hideo Satoh Japan	10	157 0.8×	62 0.4×	19 0.2×	29 0.9×	49 1.6×	25	424
Paul M. Overton United Kingdom	10	176 0.9×	76 0.4×	13 0.1×	15 0.5×	9 0.3×	10	296
Nicola V. Taverner United Kingdom	9	276 1.4×	142 0.8×	18 0.2×	6 0.2×	4 0.1×	14	409
Matthias Kohn Germany	9	224 1.1×	226 1.3×	63 0.7×	12 0.4×	6 0.2×	14	371
Liselotte Vesterlund Sweden	11	339 1.7×	106 0.6×	7 0.1×	21 0.7×	9 0.3×	14	493
Joëlle A. Desmarais Canada	12	276 1.4×	63 0.4×	15 0.2×	11 0.3×	56 1.9×	15	505
N Malik United Kingdom	4	225 1.1×	157 0.9×	12 0.1×	11 0.3×	3 0.1×	6	306
Concetta G.A. Marfella United States	9	629 3.2×	137 0.8×	9 0.1×	12 0.4×	9 0.3×	9	713

Countries citing papers authored by M. Mullarkey

Since Specialization

Citations

This map shows the geographic impact of M. Mullarkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mullarkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mullarkey more than expected).

Fields of papers citing papers by M. Mullarkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mullarkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mullarkey. The network helps show where M. Mullarkey may publish in the future.

Co-authorship network of co-authors of M. Mullarkey

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mullarkey. A scholar is included among the top collaborators of M. Mullarkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mullarkey. M. Mullarkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rea, Gillian, et al.. (2013). Subcortical white matter abnormalities because of previously undescribed de-novo 14q12–q13.1 triplication. Clinical Dysmorphology. 22(2). 71–72. 2 indexed citations

Conroy, Judith, Veronica Donoghue, M. Mullarkey, et al.. (2010). Agenesis of the corpus callosum with midline lipoma associated with an Xp22.31–Xp22.12 deletion. Clinical Dysmorphology. 20(1). 21–25. 2 indexed citations

Conroy, Judith, Lynne Cochrane, Richard Anney, et al.. (2008). Fine mapping and association studies in a candidate region for autism on chromosome 2q31–q32. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(4). 535–544. 9 indexed citations

McAuliffe, Fionnuala M., et al.. (2007). Antenatal diagnosis of deletion chromosome 11(q23-qter) (Jacobsen syndrome). Clinical Dysmorphology. 16(3). 177–179. 6 indexed citations

Stallings, Raymond L., M. Mullarkey, Michael McDermott, et al.. (2004). Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma. Cytogenetic and Genome Research. 106(1). 49–54. 10 indexed citations

Stallings, Raymond L., et al.. (2004). Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma. Cancer Genetics and Cytogenetics. 154(1). 44–51. 14 indexed citations

Stallings, R.L., Julie Howard, M. Mullarkey, et al.. (2003). Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?. Cancer Genetics and Cytogenetics. 140(2). 133–137. 28 indexed citations

McInerney, James O., et al.. (2002). Bacteria and Archaea: Molecular techniques reveal astonishing diversity. Biodiversity. 3(2). 3–10. 6 indexed citations

Mullarkey, M., et al.. (2001). Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma. Cytogenetic and Genome Research. 95(1-2). 9–11. 3 indexed citations

10.

O’Meara, Anne, et al.. (2000). Coordinate Deletion of Chromosome 3p and 11q in Neuroblastoma Detected by Comparative Genomic Hybridization. Cancer Genetics and Cytogenetics. 120(1). 44–49. 56 indexed citations

11.

Behjati, Farkhondeh, et al.. (1997). Chromosome deletion 17pl 1.2 (Smith‐Magenis syndrome) in seven new patients, four of whom had been referred for fragile‐X investigation. Clinical Genetics. 51(1). 71–74. 10 indexed citations

12.

McInerney, James O., et al.. (1997). Phylogenetic analysis of Group I marine archaeal rRNA sequences emphasizes the hidden diversity within the primary group Archaea. Proceedings of the Royal Society B Biological Sciences. 264(1388). 1663–1669. 22 indexed citations

13.

Powell, R., et al.. (1995). Detection of micro-organisms in the environment. Biochemical Society Transactions. 23(2). 435–437. 1 indexed citations

14.

Wilkie, Andrew O.M., Piers E.F. Daubeney, David Grant, et al.. (1993). Complete and partial XY sex reversal associated with terminal deletion of 10q: Report of 2 cases and literature review. American Journal of Medical Genetics. 46(5). 597–600. 103 indexed citations

15.

Barnicoat, Angela, et al.. (1993). Cytogenetic versus DNA diagnosis in routine referrais for fragile X syndrome. The Lancet. 342(8878). 1025–1026. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact